Clinical trials recruiting for NSCLC Stage IV Without EGFR/ALK Mutation
Fewer than 3 recruiting trials found.
2
Recruiting trials
0
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Benmelstobart combined with Bevacizumab and chemotherapy | 1 |
| Benmelstobart combined with chemotherapy | 1 |
| chemotherapy + PD-1 inhibitors | 1 |
Self-screener
Recruiting trials
- A Study on Exploring the Abscopal Effect Induced by Different Radioimmunotherapy Combination Patterns in the Treatment of Non-Small Cell Lung Cancer With Multiple Metastases
- Study on the Optimal Combination Pattern of the Combined Treatment of Radiotherapy and Immunotherapy for the Abscopal Effect in Non-Small Cell Lung Cancer (NSCLC) With Multiple Metastases
Related conditions
Trials recruiting for NSCLC Stage IV Without EGFR/ALK Mutation often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for NSCLC Stage IV Without EGFR/ALK Mutation trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.